Arylsulfonamides as antiviral agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S311000, C514S340000, C514S361000, C514S364000, 54, 54, C544S405000, C548S127000, C548S131000

Reexamination Certificate

active

07115612

ABSTRACT:
The present invention relates to novel sulphonamides of the general formula (I)in which the substituents R1, R2, R3, R4and A and X are as defined in claim1and other claims, and also to processes for their preparation and to their use as antiviral agents, in particular against cytomegaloviruses.

REFERENCES:
patent: 1172361 (2002-01-01), None
patent: 9937291 (1999-07-01), None
Misra, V. S., Varshneya, M., “Search for New Antiviral Agents. Part I. Synthesis of Aryl Sulfamoyl Benzamido Alkyl/Aralkyl Esters”, J. Indian Chem. Soc., 51(II):963-964 (Nov. 1974).
Database Crossfire Beilstein 'Online!, Beilstein Institut Zur Foerderung Der Wissenschaften, Frankfurt Am Main, DE; BRN 75129-34-9; XP002213430 (2003).
Database Crossfire Beilstein 'Online!, Beilstein Institut Zur Foerderung Der Wissenschaften, Frankfurt Am Main, DE; BRN 360648; XP002213431 (2003).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Arylsulfonamides as antiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Arylsulfonamides as antiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonamides as antiviral agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3633727

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.